Synbio Tech Inc.

Total Valuation

Synbio Tech Inc. carries a market capitalization of 1.70B, placing it among publicly traded companies globally. Its enterprise value stands at 3.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Synbio Tech Inc. currently has 34.48M shares outstanding.

Valuation Ratios

Synbio Tech Inc. trades at a trailing price-to-earnings ratio of 15.85. The price-to-sales ratio is 2.69, and the price-to-book ratio stands at 3.36.

Enterprise Valuation

On an enterprise value basis, Synbio Tech Inc. trades at an EV/EBITDA multiple of 19.15 and an EV/FCF ratio of 4.42. The EV/Sales ratio of 3.66 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.15 provides insight into valuation relative to core operating earnings.

Financial Position

Synbio Tech Inc. maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 104.24, indicating elevated leverage, while an interest coverage ratio of 15.62 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Synbio Tech Inc. posts a return on equity of 22.44 and a return on invested capital of 7.21.

Taxes

Over the trailing twelve months, Synbio Tech Inc. has paid 26.40M in income taxes, reflecting an effective tax rate of 13.04.

Stock Price Statistics

Synbio Tech Inc.'s stock has declined approximately -60.08097% over the past 52 weeks. The 50-day moving average sits at 51.20, while the 200-day moving average is 79.54.

Income Statement

Over the trailing twelve months, Synbio Tech Inc. generated 1.04B in revenue and converted that into 175.97M in net income, yielding earnings per share of 5.34. EBITDA reached 198.41M, while operating income came in at 198.41M.

Balance Sheet

Synbio Tech Inc. holds 376.23M in cash and equivalents against 1.39B in total debt, resulting in a net debt position of 980.67M. Total book value stands at 829.73M, with working capital of 130.31M providing operational flexibility.

Cash Flow

Synbio Tech Inc. produced 143.35M in operating cash flow over the past twelve months. After subtracting -705.01M in capital expenditures, free cash flow totaled -561.66M - equivalent to -17.11 per share.

Margins

Synbio Tech Inc. operates with a gross margin of 53.45, reflecting its pricing power and cost economics. The operating margin of 19.10 and net profit margin of 16.94 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Synbio Tech Inc.'s most recent stock split took place on August 6, 2024 with a 50:51 split ratio.

Scores

Synbio Tech Inc. posts an Altman Z-Score of 1.78, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.